The PRECISE-BTN study uses Pulse Biosciences’ Nanosecond Pulsed Field Ablation (nsPFA) technology to treat patients with benign thyroid nodules (BTNs).
Tuesday, September 30, 2025
Clinical trial testing whether an investigational drug could reduce heart attacks and mortality in individuals with a specific genetic variant following a sudden cardiac event.
Wednesday, September 24, 2025